BMY logo

Bristol-Myers Squibb (BMY) Cash from operations

annual CFO:

$15.19B+$1.33B(+9.60%)
December 31, 2024

Summary

  • As of today (May 29, 2025), BMY annual cash flow from operations is $15.19 billion, with the most recent change of +$1.33 billion (+9.60%) on December 31, 2024.
  • During the last 3 years, BMY annual CFO has fallen by -$1.02 billion (-6.28%).
  • BMY annual CFO is now -6.28% below its all-time high of $16.21 billion, reached on December 31, 2021.

Performance

BMY Cash from operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBMYcash flow metrics

quarterly CFO:

$1.95B-$2.48B(-55.98%)
March 31, 2025

Summary

  • As of today (May 29, 2025), BMY quarterly cash flow from operations is $1.95 billion, with the most recent change of -$2.48 billion (-55.98%) on March 31, 2025.
  • Over the past year, BMY quarterly CFO has dropped by -$880.00 million (-31.05%).
  • BMY quarterly CFO is now -65.05% below its all-time high of $5.59 billion, reached on September 30, 2024.

Performance

BMY quarterly CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBMYcash flow metrics

TTM CFO:

$14.31B-$880.00M(-5.79%)
March 31, 2025

Summary

  • As of today (May 29, 2025), BMY TTM cash flow from operations is $14.31 billion, with the most recent change of -$880.00 million (-5.79%) on March 31, 2025.
  • Over the past year, BMY TTM CFO has increased by +$586.00 million (+4.27%).
  • BMY TTM CFO is now -11.70% below its all-time high of $16.21 billion, reached on December 31, 2021.

Performance

BMY TTM CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBMYcash flow metrics

Cash from operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

BMY Cash from operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+9.6%-31.1%+4.3%
3 y3 years-6.3%-48.7%-11.6%
5 y5 years+85.0%-50.4%+33.0%

BMY Cash from operations Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-6.3%+16.3%-65.0%+3.5%-11.6%+20.8%
5 y5-year-6.3%+85.0%-65.0%+3.5%-11.7%+33.0%
alltimeall time-6.3%+1507.4%-65.0%+279.9%-11.7%+3636.3%

BMY Cash from operations History

DateAnnualQuarterlyTTM
Mar 2025
-
$1.95B(-56.0%)
$14.31B(-5.8%)
Dec 2024
$15.19B(+9.6%)
$4.44B(-20.6%)
$15.19B(+1.2%)
Sep 2024
-
$5.59B(+140.4%)
$15.00B(+5.9%)
Jun 2024
-
$2.33B(-17.9%)
$14.16B(+3.2%)
Mar 2024
-
$2.83B(-33.3%)
$13.72B(-1.0%)
Dec 2023
$13.86B(+6.1%)
$4.25B(-10.5%)
$13.86B(+7.3%)
Sep 2023
-
$4.75B(+151.8%)
$12.91B(+9.0%)
Jun 2023
-
$1.89B(-36.5%)
$11.85B(-3.1%)
Mar 2023
-
$2.97B(-10.2%)
$12.22B(-6.4%)
Dec 2022
$13.07B(-19.4%)
$3.31B(-10.3%)
$13.07B(-5.4%)
Sep 2022
-
$3.69B(+63.1%)
$13.82B(-10.3%)
Jun 2022
-
$2.26B(-40.7%)
$15.40B(-4.9%)
Mar 2022
-
$3.81B(-6.0%)
$16.20B(-0.1%)
Dec 2021
$16.21B(+15.3%)
$4.06B(-23.0%)
$16.21B(+4.5%)
Sep 2021
-
$5.27B(+72.1%)
$15.51B(+24.0%)
Jun 2021
-
$3.06B(-20.0%)
$12.51B(-10.3%)
Mar 2021
-
$3.82B(+14.0%)
$13.94B(-0.8%)
Dec 2020
$14.05B(+71.2%)
$3.35B(+48.0%)
$14.05B(+9.1%)
Sep 2020
-
$2.27B(-49.5%)
$12.88B(-2.2%)
Jun 2020
-
$4.49B(+14.1%)
$13.17B(+22.4%)
Mar 2020
-
$3.94B(+80.5%)
$10.76B(+31.0%)
Dec 2019
$8.21B(+16.2%)
$2.18B(-14.7%)
$8.21B(-14.3%)
Sep 2019
-
$2.56B(+22.7%)
$9.58B(+15.4%)
Jun 2019
-
$2.08B(+49.9%)
$8.31B(+14.1%)
Mar 2019
-
$1.39B(-60.9%)
$7.28B(+3.0%)
Dec 2018
$7.07B(+34.0%)
$3.56B(+178.0%)
$7.07B(+52.7%)
Sep 2018
-
$1.28B(+21.0%)
$4.63B(-8.6%)
Jun 2018
-
$1.06B(-10.0%)
$5.06B(-9.4%)
Mar 2018
-
$1.18B(+5.2%)
$5.59B(+6.0%)
Dec 2017
$5.28B(+72.5%)
$1.12B(-34.8%)
$5.28B(-5.8%)
Sep 2017
-
$1.71B(+8.1%)
$5.60B(+5.8%)
Jun 2017
-
$1.58B(+84.0%)
$5.29B(+27.6%)
Mar 2017
-
$861.00M(-40.3%)
$4.15B(+35.6%)
Dec 2016
$3.06B(+45.3%)
$1.44B(+2.8%)
$3.06B(+22.4%)
Sep 2016
-
$1.40B(+219.8%)
$2.50B(+54.4%)
Jun 2016
-
$439.00M(-292.5%)
$1.62B(+29.4%)
Mar 2016
-
-$228.00M(-125.8%)
$1.25B(-40.6%)
Dec 2015
$2.10B(-33.1%)
$884.00M(+68.7%)
$2.10B(+17.4%)
Sep 2015
-
$524.00M(+638.0%)
$1.79B(-17.4%)
Jun 2015
-
$71.00M(-88.7%)
$2.17B(-31.2%)
Mar 2015
-
$626.00M(+9.4%)
$3.16B(+0.3%)
Dec 2014
$3.15B(-11.2%)
$572.00M(-36.7%)
$3.15B(-21.0%)
Sep 2014
-
$903.00M(-14.5%)
$3.99B(-3.6%)
Jun 2014
-
$1.06B(+71.2%)
$4.14B(-9.9%)
Mar 2014
-
$617.00M(-56.2%)
$4.59B(+29.5%)
Dec 2013
$3.54B(-48.9%)
$1.41B(+33.9%)
$3.54B(+19.3%)
Sep 2013
-
$1.05B(-30.3%)
$2.97B(-54.3%)
Jun 2013
-
$1.51B(-452.8%)
$6.50B(+6.1%)
Mar 2013
-
-$428.00M(-151.2%)
$6.13B(-11.7%)
Dec 2012
$6.94B(+43.4%)
$836.00M(-81.8%)
$6.94B(-9.5%)
Sep 2012
-
$4.58B(+304.2%)
$7.67B(+60.3%)
Jun 2012
-
$1.13B(+193.0%)
$4.79B(+0.9%)
Mar 2012
-
$387.00M(-75.3%)
$4.75B(-1.9%)
Dec 2011
$4.84B(+7.8%)
$1.57B(-7.7%)
$4.84B(-0.6%)
Sep 2011
-
$1.70B(+55.4%)
$4.87B(+6.9%)
Jun 2011
-
$1.09B(+127.2%)
$4.55B(+1.0%)
Mar 2011
-
$481.00M(-69.8%)
$4.51B(+0.4%)
Dec 2010
$4.49B(+10.5%)
$1.59B(+15.3%)
$4.49B(+5.9%)
Sep 2010
-
$1.38B(+31.8%)
$4.24B(-2.1%)
Jun 2010
-
$1.05B(+126.1%)
$4.33B(+6.2%)
Mar 2010
-
$464.00M(-65.5%)
$4.08B(+0.3%)
Dec 2009
$4.07B(+9.7%)
$1.34B(-8.8%)
$4.07B(+31.7%)
Sep 2009
-
$1.47B(+85.1%)
$3.09B(+0.7%)
Jun 2009
-
$796.00M(+76.1%)
$3.07B(-9.4%)
Mar 2009
-
$452.00M(+23.5%)
$3.38B(-8.7%)
Dec 2008
$3.71B(+17.6%)
$366.00M(-74.8%)
$3.71B(-6.6%)
Sep 2008
-
$1.45B(+30.3%)
$3.97B(+23.5%)
Jun 2008
-
$1.11B(+43.7%)
$3.22B(+1.7%)
Mar 2008
-
$775.00M(+23.0%)
$3.16B(+0.3%)
Dec 2007
$3.15B
$630.00M(-9.6%)
$3.15B(+15.3%)
Sep 2007
-
$697.00M(-34.3%)
$2.73B(-8.3%)
DateAnnualQuarterlyTTM
Jun 2007
-
$1.06B(+38.7%)
$2.98B(+7.8%)
Mar 2007
-
$765.00M(+262.6%)
$2.77B(+32.7%)
Dec 2006
$2.08B(+13.5%)
$211.00M(-77.6%)
$2.08B(-4.0%)
Sep 2006
-
$944.00M(+11.7%)
$2.17B(+9.3%)
Jun 2006
-
$845.00M(+918.1%)
$1.99B(+74.7%)
Mar 2006
-
$83.00M(-72.1%)
$1.14B(-38.1%)
Dec 2005
$1.84B(-42.2%)
$297.00M(-60.9%)
$1.84B(-17.4%)
Sep 2005
-
$760.00M(<-9900.0%)
$2.22B(+8.8%)
Jun 2005
-
-$4.00M(-100.5%)
$2.04B(-29.0%)
Mar 2005
-
$783.00M(+14.6%)
$2.88B(-9.4%)
Dec 2004
$3.18B(-9.6%)
$683.00M(+17.6%)
$3.18B(-15.2%)
Sep 2004
-
$581.00M(-30.1%)
$3.74B(-9.0%)
Jun 2004
-
$831.00M(-23.1%)
$4.11B(-7.2%)
Mar 2004
-
$1.08B(-13.6%)
$4.43B(+26.2%)
Dec 2003
$3.51B(+271.6%)
$1.25B(+31.5%)
$3.51B(+19.1%)
Sep 2003
-
$951.00M(-17.3%)
$2.95B(+0.5%)
Jun 2003
-
$1.15B(+618.8%)
$2.94B(+34.0%)
Mar 2003
-
$160.00M(-76.7%)
$2.19B(+131.9%)
Dec 2002
$945.00M(-82.5%)
$688.00M(-26.6%)
$945.00M(-57.5%)
Sep 2002
-
$937.00M(+130.8%)
$2.22B(-5.0%)
Jun 2002
-
$406.00M(-137.4%)
$2.34B(-32.1%)
Mar 2002
-
-$1.09B(-155.2%)
$3.45B(-36.2%)
Dec 2001
$5.40B(+16.1%)
$1.97B(+86.7%)
$5.40B(+2.8%)
Sep 2001
-
$1.05B(-30.4%)
$5.26B(-2.5%)
Jun 2001
-
$1.51B(+74.2%)
$5.39B(+12.0%)
Mar 2001
-
$869.00M(-52.3%)
$4.82B(+3.5%)
Dec 2000
$4.65B(+10.1%)
$1.82B(+53.2%)
$4.65B(+6.2%)
Sep 2000
-
$1.19B(+26.7%)
$4.38B(+2.3%)
Jun 2000
-
$938.00M(+32.9%)
$4.28B(+1.7%)
Mar 2000
-
$706.00M(-54.5%)
$4.21B(-0.4%)
Dec 1999
$4.22B(+11.7%)
$1.55B(+42.5%)
$4.22B(+11.8%)
Sep 1999
-
$1.09B(+25.8%)
$3.78B(-5.8%)
Jun 1999
-
$865.00M(+20.0%)
$4.01B(+10.7%)
Mar 1999
-
$721.00M(-34.8%)
$3.62B(-4.2%)
Dec 1998
$3.78B(+52.7%)
$1.10B(-16.2%)
$3.78B(+15.7%)
Sep 1998
-
$1.32B(+175.9%)
$3.27B(+17.8%)
Jun 1998
-
$478.00M(-45.7%)
$2.78B(+4.0%)
Mar 1998
-
$880.00M(+48.4%)
$2.67B(+7.8%)
Dec 1997
$2.48B(-6.2%)
$593.00M(-28.1%)
$2.48B(-2.6%)
Sep 1997
-
$825.00M(+122.4%)
$2.54B(+3.4%)
Jun 1997
-
$371.00M(-46.0%)
$2.46B(-9.4%)
Mar 1997
-
$687.00M(+4.4%)
$2.71B(+2.7%)
Dec 1996
$2.64B(+5.7%)
$658.00M(-11.3%)
$2.64B(+0.6%)
Sep 1996
-
$742.00M(+18.5%)
$2.63B(-0.9%)
Jun 1996
-
$626.00M(+1.8%)
$2.65B(+12.2%)
Mar 1996
-
$615.00M(-4.2%)
$2.36B(-5.5%)
Dec 1995
$2.50B(+8.6%)
$642.00M(-16.3%)
$2.50B(-0.5%)
Sep 1995
-
$767.00M(+127.6%)
$2.51B(+12.7%)
Jun 1995
-
$337.00M(-55.2%)
$2.23B(-5.5%)
Mar 1995
-
$753.00M(+15.0%)
$2.36B(+2.5%)
Dec 1994
$2.30B(-10.8%)
$655.00M(+35.3%)
$2.30B(-4.5%)
Sep 1994
-
$484.00M(+3.9%)
$2.41B(-11.8%)
Jun 1994
-
$466.00M(-33.0%)
$2.73B(-4.5%)
Mar 1994
-
$696.00M(-8.9%)
$2.86B(+11.0%)
Dec 1993
$2.58B(+27.2%)
$764.00M(-5.3%)
$2.58B(+4.9%)
Sep 1993
-
$807.00M(+35.4%)
$2.46B(+5.1%)
Jun 1993
-
$596.00M(+44.3%)
$2.34B(+14.6%)
Mar 1993
-
$413.00M(-35.9%)
$2.04B(+0.7%)
Dec 1992
$2.03B(+10.5%)
$644.00M(-6.4%)
$2.03B(-0.8%)
Sep 1992
-
$688.00M(+130.9%)
$2.04B(+10.0%)
Jun 1992
-
$298.00M(-25.1%)
$1.86B(-0.1%)
Mar 1992
-
$398.00M(-39.7%)
$1.86B(+1.4%)
Dec 1991
$1.83B(+4.7%)
$660.00M(+31.2%)
$1.83B(+6.9%)
Sep 1991
-
$503.00M(+67.7%)
$1.72B(+3.7%)
Jun 1991
-
$300.00M(-19.4%)
$1.65B(-5.0%)
Mar 1991
-
$372.00M(-31.2%)
$1.74B(-0.6%)
Dec 1990
$1.75B(+47.2%)
$541.00M(+22.7%)
$1.75B(+44.7%)
Sep 1990
-
$441.00M(+14.0%)
$1.21B(+57.3%)
Jun 1990
-
$387.00M(+1.0%)
$770.00M(+101.0%)
Mar 1990
-
$383.00M
$383.00M
Dec 1989
$1.19B
-
-

FAQ

  • What is Bristol-Myers Squibb annual cash flow from operations?
  • What is the all time high annual CFO for Bristol-Myers Squibb?
  • What is Bristol-Myers Squibb annual CFO year-on-year change?
  • What is Bristol-Myers Squibb quarterly cash flow from operations?
  • What is the all time high quarterly CFO for Bristol-Myers Squibb?
  • What is Bristol-Myers Squibb quarterly CFO year-on-year change?
  • What is Bristol-Myers Squibb TTM cash flow from operations?
  • What is the all time high TTM CFO for Bristol-Myers Squibb?
  • What is Bristol-Myers Squibb TTM CFO year-on-year change?

What is Bristol-Myers Squibb annual cash flow from operations?

The current annual CFO of BMY is $15.19B

What is the all time high annual CFO for Bristol-Myers Squibb?

Bristol-Myers Squibb all-time high annual cash flow from operations is $16.21B

What is Bristol-Myers Squibb annual CFO year-on-year change?

Over the past year, BMY annual cash flow from operations has changed by +$1.33B (+9.60%)

What is Bristol-Myers Squibb quarterly cash flow from operations?

The current quarterly CFO of BMY is $1.95B

What is the all time high quarterly CFO for Bristol-Myers Squibb?

Bristol-Myers Squibb all-time high quarterly cash flow from operations is $5.59B

What is Bristol-Myers Squibb quarterly CFO year-on-year change?

Over the past year, BMY quarterly cash flow from operations has changed by -$880.00M (-31.05%)

What is Bristol-Myers Squibb TTM cash flow from operations?

The current TTM CFO of BMY is $14.31B

What is the all time high TTM CFO for Bristol-Myers Squibb?

Bristol-Myers Squibb all-time high TTM cash flow from operations is $16.21B

What is Bristol-Myers Squibb TTM CFO year-on-year change?

Over the past year, BMY TTM cash flow from operations has changed by +$586.00M (+4.27%)
On this page